PL310821A1 - Aluminium containing pharmaceutical preparation of controllable active substance release - Google Patents
Aluminium containing pharmaceutical preparation of controllable active substance releaseInfo
- Publication number
- PL310821A1 PL310821A1 PL94310821A PL31082194A PL310821A1 PL 310821 A1 PL310821 A1 PL 310821A1 PL 94310821 A PL94310821 A PL 94310821A PL 31082194 A PL31082194 A PL 31082194A PL 310821 A1 PL310821 A1 PL 310821A1
- Authority
- PL
- Poland
- Prior art keywords
- active substance
- pharmaceutical preparation
- containing pharmaceutical
- substance release
- aluminium containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9300744A HUT70038A (en) | 1992-03-16 | 1993-03-16 | 2-oxoquinolines, pharmaceutical compositions containing them, and the process for preparing thereof |
| PCT/EP1994/000829 WO1994021268A1 (en) | 1993-03-16 | 1994-03-16 | Aluminium containing pharmaceutical preparation with controlled release |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL310821A1 true PL310821A1 (en) | 1996-01-08 |
Family
ID=10983353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL94310821A PL310821A1 (en) | 1993-03-16 | 1994-03-16 | Aluminium containing pharmaceutical preparation of controllable active substance release |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0689445A1 (en) |
| JP (1) | JPH08507775A (en) |
| AU (1) | AU6426994A (en) |
| CA (1) | CA2158437A1 (en) |
| FI (1) | FI954348L (en) |
| PL (1) | PL310821A1 (en) |
| WO (1) | WO1994021268A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4424675A1 (en) * | 1994-07-13 | 1996-01-18 | Bayer Ag | Antacid preparation with improved safety profile |
| KR20040089628A (en) * | 2002-03-04 | 2004-10-21 | 가부시키가이샤 메드렉스 | Liquid matrix undergoing phase transfer in vivo and liquid oral preparations |
| AU2014227790B2 (en) | 2013-03-15 | 2019-03-14 | Mallinckrodt Hospital Products IP Limited | Therapeutic gas delivery device with pulsed and continuous flow control |
| CN114917198B (en) * | 2022-06-22 | 2023-05-12 | 海南妙音春制药有限公司 | Aluminum magnesium carbonate chewable tablet and preparation method thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3579634A (en) * | 1968-04-18 | 1971-05-18 | Garland Richard Brown | Novel antacid compositions and methods for their administration |
| US3591680A (en) * | 1969-11-17 | 1971-07-06 | Smith Kline French Lab | Concentrated antacid compositions and method of producing antacid activity |
| FR2153174B1 (en) * | 1971-09-23 | 1976-04-16 | Biotherax Lab | |
| GB1601833A (en) * | 1978-02-06 | 1981-11-04 | Wellcome Found | Antacid formulation |
| FR2512344A1 (en) * | 1981-09-08 | 1983-03-11 | Af Aplicaciones Far Lab | Stable antacid suspension of aluminium and/or magnesium hydroxide(s) - prepd. by mixing powdered prod. with water, fragmenting and dispersing to give particle size of 5-10 microns |
| GB2201594B (en) * | 1986-06-24 | 1991-02-13 | Istvan Racz | Production of acid binding pharmaceutical preparations |
| EP0484106A1 (en) * | 1990-11-01 | 1992-05-06 | Merck & Co. Inc. | Controlled release formulations |
-
1994
- 1994-03-16 CA CA002158437A patent/CA2158437A1/en not_active Abandoned
- 1994-03-16 FI FI954348A patent/FI954348L/en not_active Application Discontinuation
- 1994-03-16 WO PCT/EP1994/000829 patent/WO1994021268A1/en not_active Ceased
- 1994-03-16 JP JP6520643A patent/JPH08507775A/en active Pending
- 1994-03-16 EP EP94911900A patent/EP0689445A1/en not_active Withdrawn
- 1994-03-16 PL PL94310821A patent/PL310821A1/en unknown
- 1994-03-16 AU AU64269/94A patent/AU6426994A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0689445A1 (en) | 1996-01-03 |
| AU6426994A (en) | 1994-10-11 |
| CA2158437A1 (en) | 1994-09-29 |
| FI954348A7 (en) | 1995-11-15 |
| FI954348L (en) | 1995-11-15 |
| JPH08507775A (en) | 1996-08-20 |
| WO1994021268A1 (en) | 1994-09-29 |
| FI954348A0 (en) | 1995-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL313386A1 (en) | Novel pearls ensuring controllable drug release and pharmaceutic preparation containing them | |
| HRP920229A2 (en) | Release of medicinal substances and preparation process therefor | |
| EP0224146A3 (en) | Pharmaceutical preparation for the controlled release of active ingredients | |
| IL105966A0 (en) | Preparation of clavulanic acid | |
| AU7208494A (en) | Controlled release of pharmaceutically active substances from coacervate microcapsules | |
| HU9301700D0 (en) | Methods for producing biphenylic derivatives and pharmaceutical preparatives containing them as active substance | |
| IL105222A0 (en) | Cyclohex-1-ene compounds and pharmaceutical compositions containing them | |
| ZA988718B (en) | Drug formulation having controlled release of active compound | |
| SG43083A1 (en) | Benzinidaziles pharmaceutical compositions containing these compounds and processes for preparing them | |
| IL116771A (en) | 9-Substituted 2-(2-n-alkoxyphenyl) purin-6-one compounds their preparation and pharmaceutical compositions containing them | |
| PL299369A1 (en) | Novel epoxy compounds, method of obtainining them and pharmaceutical preparation containing them | |
| HUT75029A (en) | Systems for controlled release of pilocarpine, and semipermeable capsule containing the active ingredient | |
| AP9300581A0 (en) | Benzofuran derivatives processes for their preparation and pharmaceutical compositions containing them and their medical use | |
| PL327584A1 (en) | Active substance quckly releasing tablet containing tolphenamica acid or its pharmaceutically acceptable salt | |
| PL310821A1 (en) | Aluminium containing pharmaceutical preparation of controllable active substance release | |
| IL117078A0 (en) | Substituted benzenesulfonylureas and -thioureas processes for their preparation their use for the production of pharmaceutical preparations and pharmaceutical preparations containing them | |
| SI0871616T1 (en) | Process for the preparation of anti-malarial drugs | |
| IL117152A0 (en) | Substituted benzenesulfonylureas and -thioureas processes for their preparation and use of pharmaceutical preparation based on these compounds and medicaments containing them | |
| AU5560694A (en) | Pharmaceutical formulations of ibuprofen | |
| CZ87895A3 (en) | Pharmaceutical preparation | |
| IL117179A0 (en) | Substituted benzenesulfonylureas and -thioureas processes for their preparation and use of pharmaceutical preparations based on these compounds and medicaments containing them | |
| GB9304745D0 (en) | Use of pharmaceutical formulations | |
| HUT74076A (en) | Pharmaceutical preparation containing penciclorin for the treatment of post-therapeutic neuralgia | |
| IL103411A0 (en) | Pharmaceutical formulation for controlled release of melatonin | |
| IL105870A0 (en) | Pharmaceutical soft capsules containing lysine clonixinate and their preparation |